These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24785213)

  • 1. Genotype-guided dosing of vitamin K antagonists.
    Kimmel SE; French B; Geller NL;
    N Engl J Med; 2014 May; 370(18):1763-4. PubMed ID: 24785213
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype-guided dosing of vitamin K antagonists.
    Cavallari LH; Kittles RA; Perera MA
    N Engl J Med; 2014 May; 370(18):1763. PubMed ID: 24785218
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotype-guided dosing of vitamin K antagonists.
    Koller EA; Roche JC; Rollins JA
    N Engl J Med; 2014 May; 370(18):1761. PubMed ID: 24785214
    [No Abstract]   [Full Text] [Related]  

  • 4. Genotype-guided dosing of vitamin K antagonists.
    Pirmohamed M; Wadelius M; Kamali F;
    N Engl J Med; 2014 May; 370(18):1764-5. PubMed ID: 24804303
    [No Abstract]   [Full Text] [Related]  

  • 5. Genotype-guided dosing of vitamin K antagonists.
    Maitland-van der Zee AH; de Boer A; Manolopoulos VG;
    N Engl J Med; 2014 May; 370(18):1765-6. PubMed ID: 24804306
    [No Abstract]   [Full Text] [Related]  

  • 6. Do pharmacogenetics have a role in the dosing of vitamin K antagonists?
    Furie B
    N Engl J Med; 2013 Dec; 369(24):2345-6. PubMed ID: 24251364
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics and coumarin dosing--recalibrating expectations.
    Zineh I; Pacanowski M; Woodcock J
    N Engl J Med; 2013 Dec; 369(24):2273-5. PubMed ID: 24328463
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.
    Roberts A
    Nat Rev Cardiol; 2014 Jan; 11(1):1. PubMed ID: 24302217
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients benefit from genetics-guided coumarin anticoagulant therapy.
    Maitland-van der Zee AH; Daly AK; Kamali F; Manolopoulous VG; Verhoef TI; Wadelius M; de Boer A; Pirmohamed M;
    Clin Pharmacol Ther; 2014 Jul; 96(1):15-7. PubMed ID: 24942396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
    Verhoef TI; Ragia G; de Boer A; Barallon R; Kolovou G; Kolovou V; Konstantinides S; Le Cessie S; Maltezos E; van der Meer FJ; Redekop WK; Remkes M; Rosendaal FR; van Schie RM; Tavridou A; Tziakas D; Wadelius M; Manolopoulos VG; Maitland-van der Zee AH;
    N Engl J Med; 2013 Dec; 369(24):2304-12. PubMed ID: 24251360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin, genes, and the (health care) environment.
    Kazi DS; Hlatky MA
    JAMA Intern Med; 2014 Aug; 174(8):1338-9. PubMed ID: 24934523
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of pharmacogenetic testing.
    Pocinki AG
    JAMA Intern Med; 2015 Feb; 175(2):314. PubMed ID: 25642672
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of pharmacogenetic testing—reply.
    Kazi DS; Hlatky MA
    JAMA Intern Med; 2015 Feb; 175(2):314-5. PubMed ID: 25642673
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.
    Verhoef TI; Redekop WK; Daly AK; van Schie RM; de Boer A; Maitland-van der Zee AH
    Br J Clin Pharmacol; 2014 Apr; 77(4):626-41. PubMed ID: 23919835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-guided dosing of vitamin K antagonists.
    Pereira NL; Rihal CS; Weinshilboum RM
    N Engl J Med; 2014 May; 370(18):1762. PubMed ID: 24785216
    [No Abstract]   [Full Text] [Related]  

  • 16. Genotype-guided dosing of vitamin K antagonists.
    Schwarz UI; Kim RB; Tirona RG
    N Engl J Med; 2014 May; 370(18):1761-2. PubMed ID: 24785215
    [No Abstract]   [Full Text] [Related]  

  • 17. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
    Stergiopoulos K; Brown DL
    JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-guided dosing of vitamin K antagonists.
    Daneshjou R; Klein TE; Altman RB
    N Engl J Med; 2014 May; 370(18):1762-3. PubMed ID: 24785217
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the -1639G > A polymorphism of the VKORC1 gene on the dose of oral anticoagulants acenocoumarol, and warfarin in Chilean patients: alternative models of inheritance].
    López-Hernández D
    Rev Med Chil; 2016 Apr; 144(4):539-41. PubMed ID: 27401392
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin dosing by genotype did not improve time in therapeutic range.
    Dunn A
    Ann Intern Med; 2014 Mar; 160(6):JC8. PubMed ID: 24638186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.